Science 2009, 324:930–935 PubMedCentralPubMedCrossRef 8 Kriaucio

Science 2009, 324:930–935.PubMedCentralPubMedCrossRef 8. Kriaucionis S, Heintz N: The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 2009, 324:929–930.PubMedCentralPubMedCrossRef 9. Ito S, D’Alessio AC, Taranova OV, Hong K, Sowers LC, Zhang Y: Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature 2010, 466:1129–1133.PubMedCentralPubMedCrossRef 10. Szwagierczak A, Bultmann S, Schmidt CS, Spada F, Leonhardt H: Sensitive

enzymatic quantification of 5-hydroxymethylcytosine in genomic DNA. Nucleic Acids Res 2010, 38:e181.PubMedCentralPubMedCrossRef 11. Lian CG, Xu Y, Ceol C, Wu F, Larson FK228 A, Dresser

K, Xu W, Tan L, E7080 research buy Hu Y, Zhan Q, Lee CW, Hu D, Lian BQ, Kleffel S, Yang Y, Neiswender J, Khorasani AJ, Fang R, Lezcano C, Duncan LM, Scolyer RA, Thompson JF, Kakavand H, Houvras Y, Zon LI, Mihm MC Jr, Kaiser UB, Schatton T, Woda BA, Murphy GF: Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma. Cell 2012, 150:1135–1146.PubMedCentralPubMedCrossRef 12. Orr BA, Haffner MC, Nelson WG, Yegnasubramanian S, Eberhart CG: Decreased 5-hydroxymethylcytosine is associated with neural progenitor phenotype in normal brain and shorter survival in malignant glioma. PloS One 2012, 7:e41036.PubMedCentralPubMedCrossRef 13. Kudo Y, Tateishi K, Protein Tyrosine Kinase inhibitor Yamamoto K, Yamamoto S, Asaoka Y, Ijichi H, Nagae G, Yoshida H, Aburatani H, Koike K: Loss of 5-hydroxymethylcytosine is accompanied with malignant cellular transformation. Cancer Sci 2012, 103:670–676.PubMedCrossRef 14. Yang H, Liu Y, Bai F, Zhang JY, Ma SH, Liu J, Xu ZD, Zhu HG, Ling ZQ, Ye D, Guan KL, Xiong Y: Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation. Oncogene 2013, 32:663–669.PubMedCentralPubMedCrossRef Ketotifen 15. Jin SG, Jiang Y, Qiu R, Rauch TA, Wang Y, Schackert G,

Krex D, Lu Q, Pfeifer GP: 5-Hydroxymethylcytosine is strongly depleted in human cancers but its levels do not correlate with IDH1 mutations. Cancer Res 2011, 71:7360–7365.PubMedCentralPubMedCrossRef 16. Chen ML, Shen F, Huang W, Qi JH, Wang Y, Feng YQ, Liu SM, Yuan BF: Quantification of 5-methylcytosine and 5-hydroxymethylcytosine in genomic DNA from hepatocellular carcinoma tissues by capillary hydrophilic-interaction liquid chromatography/quadrupole TOF mass spectrometry. Clin Chem 2013, 59:824–832.PubMedCrossRef 17. Reitman ZJ, Jin G, Karoly ED, Spasojevic I, Yang J, Kinzler KW, He Y, Bigner DD, Vogelstein B, Yan H: Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome. Proc Natl Acad Sci U S A 2011, 108:3270–3275.PubMedCentralPubMedCrossRef 18.

Comments are closed.